Cargando…

Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis

The performance of polyclonal monospecific rabbit anti-sera raised against synthetic peptides derived from conserved HCV sequences of genotype 4 was evaluated for efficient detection of viral core and E1 antigens in circulating immune complexes (ICs) precipitated from 65 serum samples of HCV patient...

Descripción completa

Detalles Bibliográficos
Autores principales: El Awady, Mostafa K, El Abd, Yasmine S, Shoeb, Hussein A, Tabll, Ashraf A, Hosny, Alaa El Din MS, El Shenawy, Reem M, Atef, Khaled, Bader El Din, Noha G, Bahgat, Mahmoud M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586018/
https://www.ncbi.nlm.nih.gov/pubmed/16948845
http://dx.doi.org/10.1186/1743-422X-3-67
_version_ 1782130343874134016
author El Awady, Mostafa K
El Abd, Yasmine S
Shoeb, Hussein A
Tabll, Ashraf A
Hosny, Alaa El Din MS
El Shenawy, Reem M
Atef, Khaled
Bader El Din, Noha G
Bahgat, Mahmoud M
author_facet El Awady, Mostafa K
El Abd, Yasmine S
Shoeb, Hussein A
Tabll, Ashraf A
Hosny, Alaa El Din MS
El Shenawy, Reem M
Atef, Khaled
Bader El Din, Noha G
Bahgat, Mahmoud M
author_sort El Awady, Mostafa K
collection PubMed
description The performance of polyclonal monospecific rabbit anti-sera raised against synthetic peptides derived from conserved HCV sequences of genotype 4 was evaluated for efficient detection of viral core and E1 antigens in circulating immune complexes (ICs) precipitated from 65 serum samples of HCV patients. The infection was established in those patients by the presence of HCV RNA in their sera. A novel enzyme-linked immunosorbent assay (ELISA) was developed for the detection of HCV core and E1 antigen in serum samples. Western blot analyses were used to demonstrate the presence of the core and E1 target antigen in serum samples. The mean OD readings of both core and E1 antigens were significantly higher (P < 0.05) among the viremic patients when compared to controls. Also a significant positive correlation (P < 0.05, r = 0.98) between the values of both core and E1 was recorded. Western blot analysis based on monospecific antibodies against core and E1 recognized the 38-kDa and 88 -kDa bands respectively in the sera of all infected patients. No specific reaction was observed with the sera from uninfected individuals. Interestingly the results of core and E1 antigen levels displayed no positive correlation with the HCV copy number as measured by bDNA. Liver enzymes (ALT and AST) showed a moderate positive correlation (r = 0.44 and 0.47 respectively) with the viral core antigens level. The same trend holds true for E1 (r = 0.43 and 0.64 for ALT and AST respectively). HCV load in infected patients revealed extremely poor correlation with serum ALT and AST levels (r = 0.022 and 0.002 respectively). In conclusion we present a new combination of serological tools correlating with liver enzyme levels that could be utilized as supplemental tests to viral load testing. Also, a sensitive and specific immunoassay was developed for the detection of HCV core and E1 in human serum. This test can be applied for laboratory diagnosis of HCV infection.
format Text
id pubmed-1586018
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15860182006-09-30 Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis El Awady, Mostafa K El Abd, Yasmine S Shoeb, Hussein A Tabll, Ashraf A Hosny, Alaa El Din MS El Shenawy, Reem M Atef, Khaled Bader El Din, Noha G Bahgat, Mahmoud M Virol J Research The performance of polyclonal monospecific rabbit anti-sera raised against synthetic peptides derived from conserved HCV sequences of genotype 4 was evaluated for efficient detection of viral core and E1 antigens in circulating immune complexes (ICs) precipitated from 65 serum samples of HCV patients. The infection was established in those patients by the presence of HCV RNA in their sera. A novel enzyme-linked immunosorbent assay (ELISA) was developed for the detection of HCV core and E1 antigen in serum samples. Western blot analyses were used to demonstrate the presence of the core and E1 target antigen in serum samples. The mean OD readings of both core and E1 antigens were significantly higher (P < 0.05) among the viremic patients when compared to controls. Also a significant positive correlation (P < 0.05, r = 0.98) between the values of both core and E1 was recorded. Western blot analysis based on monospecific antibodies against core and E1 recognized the 38-kDa and 88 -kDa bands respectively in the sera of all infected patients. No specific reaction was observed with the sera from uninfected individuals. Interestingly the results of core and E1 antigen levels displayed no positive correlation with the HCV copy number as measured by bDNA. Liver enzymes (ALT and AST) showed a moderate positive correlation (r = 0.44 and 0.47 respectively) with the viral core antigens level. The same trend holds true for E1 (r = 0.43 and 0.64 for ALT and AST respectively). HCV load in infected patients revealed extremely poor correlation with serum ALT and AST levels (r = 0.022 and 0.002 respectively). In conclusion we present a new combination of serological tools correlating with liver enzyme levels that could be utilized as supplemental tests to viral load testing. Also, a sensitive and specific immunoassay was developed for the detection of HCV core and E1 in human serum. This test can be applied for laboratory diagnosis of HCV infection. BioMed Central 2006-09-01 /pmc/articles/PMC1586018/ /pubmed/16948845 http://dx.doi.org/10.1186/1743-422X-3-67 Text en Copyright © 2006 El Awady et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
El Awady, Mostafa K
El Abd, Yasmine S
Shoeb, Hussein A
Tabll, Ashraf A
Hosny, Alaa El Din MS
El Shenawy, Reem M
Atef, Khaled
Bader El Din, Noha G
Bahgat, Mahmoud M
Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
title Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
title_full Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
title_fullStr Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
title_full_unstemmed Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
title_short Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
title_sort circulating viral core and e1 antigen levels as supplemental markers for hcv chronic hepatitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586018/
https://www.ncbi.nlm.nih.gov/pubmed/16948845
http://dx.doi.org/10.1186/1743-422X-3-67
work_keys_str_mv AT elawadymostafak circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT elabdyasmines circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT shoebhusseina circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT tabllashrafa circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT hosnyalaaeldinms circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT elshenawyreemm circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT atefkhaled circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT badereldinnohag circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis
AT bahgatmahmoudm circulatingviralcoreande1antigenlevelsassupplementalmarkersforhcvchronichepatitis